34th Annual Congress of Clinical Rheumatology

Date & Location
Thursday, May 17, 2018, 7:50 AM - Sunday, May 20, 2018, 11:15 AM, Sandestin Hilton, Destin, FL

Target Audience
Dermatology, Family Practice, General Practice, Internal Medicine, Nurse Practitioner, Orthopedic Surgery, Physician Assistant, Rheumatology

The Congress of Clinical Rheumatology is an up-to-date, evidenced-based clinically oriented program with a distinguished international faculty. Application of the latest developments and cutting edge therapeutics pertinent to the clinical practice of rheumatology are discussed in order to meet the needs of practicing rheumatologists. The program consists of didactic lectures, interactive sessions, clinical management sessions (i.e. Thieves Market), question and answer sessions and the opportunity for participants to personally interact with the highly respected faculty for consultation about guidelines or patient treatment options. The educational content is designed for smooth implementation into the registrants’ practices to improve practice performance and patient outcomes, thereby improving patients’ quality of life, decreasing disability and potentially prolonging their overall survival.

  1. - 1. Evaluate and employ the most recent updates in the pathogenesis and treatment of rheumatoid arthritis, psoriatic arthritis and spondyloarthritis for best outcomes.
  2. 2. Correctly identify and manage common skin and other extra-articular manifestations of rheumatologic disease.
  3. 3. Describe currently available medications for gout, including their side effects, and design an appropriate gout treatment plan for different patient profiles.
  4. 4. Explain current recommendations for the treatment of systemic lupus erythematosus.
  5. 5. Discuss new and emerging targets for therapies in systemic lupus erythematosus and explain how they differ from currently available therapies.
  6. 6. Describe typical and atypical presentations for Lyme disease as well as current recommendations for the treatment of acute and chronic disease.
  7. 7. Summarize the symptoms, diagnosis and treatment of interstitial lung disease in connective tissue disease patients.
  8. 8. Utilize new concepts to construct a treatment plan for ANCA associated vasculitis.
  9. 9. Specify advances in the pathogenesis and new treatment targets in systemic vasculitis.
  10. 10. Define new guidelines and emerging therapies for scleroderma.

VCU Health Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.